Michael LaFerney | Medicine | Medical Hypothesis Award

Medical Hypothesis Award

Michael LaFerney
Healthdrive, United States

Michael LaFerney
Affiliation Healthdrive
Country United States
Scopus ID 54934472800
Documents 3
Citations 2
h-index 1
Subject Area Medicine
Event International Research Hypothesis Excellence Award

Michael LaFerney is a researcher associated with Healthdrive in the United States whose indexed research record is situated within the field of Medicine. The supplied bibliographic record identifies a publication concerning the psychological and physical consequences of hazing and approaches that may assist affected individuals in recovery. His Scopus profile is reported as containing three documents, two citations, and an h-index of 1. [1]

Abstract

Michael LaFerney’s documented research profile is associated with Medicine and includes scholarly work addressing the consequences of hazing. The supplied publication record, You Can Help Victims of Hazing Recover From Psychological and Physical Harm, published in Current Psychiatry in 2016, focuses on the recognition and recovery of psychological and physical harm experienced by individuals affected by hazing. [2] The topic intersects with clinical, psychological, behavioral, and public-health considerations relevant to the assessment and support of affected populations.

Keywords

  • Medical Hypothesis
  • Medicine
  • Hazing
  • Psychological Harm
  • Physical Harm
  • Recovery and Support
  • Clinical Research
  • Health Research

Introduction

Hazing describes practices or activities that can expose individuals to physical, psychological, social, or other forms of harm. From a medical perspective, responses to hazing-related harm can involve recognition of symptoms, assessment of immediate needs, psychological support, and appropriate clinical or community-based intervention. LaFerney’s identified 2016 contribution addresses the recovery of victims from psychological and physical harm, placing the subject within a broader healthcare context. [2]

Research Profile

The available profile identifies Michael LaFerney with Healthdrive and places his subject area within Medicine. His Scopus Author ID is 54934472800. The supplied Scopus indicators comprise three indexed documents, two citations, and an h-index of 1. [1] These bibliometric indicators provide a quantitative description of the indexed record but do not independently measure the clinical usefulness, methodological quality, or broader social significance of individual publications.

Research Contributions

The documented contribution available for this profile centers on the clinical and recovery dimensions of hazing-related harm. The 2016 Current Psychiatry publication addresses both psychological and physical consequences and discusses the possibility of helping affected individuals recover. [2] Within a medical research context, this topic can be considered in relation to patient recognition, psychosocial support, prevention, and pathways to appropriate care.

Publications

The supplied publication information identifies the following work:

  • LaFerney, Michael C. (2016). You Can Help Victims of Hazing Recover From Psychological and Physical Harm. Current Psychiatry. [2]

No DOI was supplied in the source information accompanying this profile. A DOI is therefore not asserted here without an independently verified bibliographic identifier.

Research Impact

The available bibliometric record reports two citations across three indexed documents and an h-index of 1. [1] These figures indicate measurable citation activity within the indexed record. Citation counts are dynamic and can change as databases are updated, while differences between indexing systems may result in different totals.

The subject of hazing-related psychological and physical harm also has practical relevance to health professionals and institutions responsible for supporting affected individuals. The identified publication contributes to this area by addressing recovery from harm rather than treating hazing solely as an institutional or social issue. [2]

Award Suitability

The International Research Hypothesis Excellence Award is identified for this profile as the associated recognition event. The documented medical subject area and the identified publication concerning recovery from psychological and physical harm provide material that can be considered by an award committee when reviewing a nominee’s research record. [1] [2]

Conclusion

Michael LaFerney’s available academic profile places his work within Medicine and identifies a publication addressing the psychological and physical consequences of hazing and recovery from related harm. [2] The supplied Scopus information records three documents, two citations, and an h-index of 1 under Author ID 54934472800. [1] Together, these records provide a concise basis for documenting the research profile while recognizing that a complete scholarly evaluation would require consideration of the full publication record, methodology, clinical relevance, and other evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Michael LaFerney, Author ID 54934472800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=54934472800
  2. LaFerney, Michael C. (2016). You Can Help Victims of Hazing Recover From Psychological and Physical Harm. Current Psychiatry.
    Bibliographic information supplied for the present researcher profile.

Patrice Cacoub | Medicine and Health Sciences | Excellence in Research Award

Prof. Patrice Cacoub | Medicine and Health Sciences | Excellence in Research Award

Medicine and Health Sciences | Professor | Sorbonne University | France

Prof. Patrice Cacoub is a distinguished clinician‐scientist whose education includes medical training leading to a doctorate and professorial appointment at Sorbonne Université, France, where he holds the chair in internal medicine and leads the Inflammation–Immunopathology–Biotherapy unit; he has also completed additional specialization in immunology, hepatology, and systemic diseases. In his professional experience he serves in leadership roles in hospital and university settings, supervises clinical and translational research groups, and participates actively in international consortia; Prof. Patrice Cacoub has authored 1,011 documents, 53,959 citations, 114 h‐index reflecting prolific output and high influence in his field. His research interests focus on autoimmune diseases, vasculitis, hepatitis C and its extrahepatic manifestations, cryoglobulinaemia, systemic inflammatory disorders, and intersecting fields of immunopathology and therapeutic intervention. He has developed strong research skills in clinical trial design, cohort studies, translational biomarkers, immunological assays, epidemiology, and patient‐oriented outcomes, complemented by skills in multidisciplinary collaboration, grant writing, statistical modelling, and supervising PhD students. His awards and honours include prestigious recognitions by national and international societies in medicine and immunology, election to leadership in professional organizations, invitations to keynote symposia, editorial board memberships, and distinguished lifetime or senior researcher awards, underscoring both scientific merit and impact in patient care. In conclusion Prof. Patrice Cacoub’s combination of rigorous academic training, sustained high‐volume publication record, leadership in clinical and translational research, and demonstrable contributions to improving understanding and treatment of systemic inflammatory and infectious disease places him among the top global experts; his work not only advances knowledge but shapes guidelines, influences public health policy, and serves as a foundation for mentoring and training new generations of researchers.

Profile:  Scopus | ORCID | Google scholar

Selected Publications

  1. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events — 2006 — ~3,652 citations

  2. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease — 1995 — ~3,202 citations

  3. Iron deficiency anaemia — 2016 — ~1,096 citations

  4. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial — 2004 — ~1,039 citations

  5. The DRESS Syndrome: A Literature Review — 2011 — ~1,001 citations

  6. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial — 2007 — ~921 citations